Literature DB >> 24372779

Helicobacter canis bacteremia in a renal transplant patient.

M L van der Vusse1, W J van Son, A Ott, W Manson.   

Abstract

Here we present a case report of a 41-year-old woman suffering from high fever and bacteremia due to Helicobacter canis, 11 months after kidney transplantation. Identification of H. canis was achieved by 16s rDNA sequence analysis of a positive blood culture. The patient was restored fully to health after antibiotics therapy (cefuroxime and ciprofloxacin). Until now, only 4 human clinical cases have been described with H. canis bacteremia. This study describes for the first time, to our knowledge, an infection with H. canis in a kidney transplant patient.
© 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Helicobacter canis; bacteremia; immunocompromised host; kidney transplant; treatment

Mesh:

Substances:

Year:  2013        PMID: 24372779     DOI: 10.1111/tid.12174

Source DB:  PubMed          Journal:  Transpl Infect Dis        ISSN: 1398-2273            Impact factor:   2.228


  4 in total

1.  Sepsis Due to a Novel Urease-Positive Helicobacter Species in a Young Man.

Authors:  Nobuaki Mori; Narito Kagawa; Akiko Higuchi; Yasuko Aoki; Kiyofumi Ohkusu
Journal:  J Clin Microbiol       Date:  2015-04-29       Impact factor: 5.948

2.  Helicobacter canis bacteraemia and cellulitis in a patient with end-stage renal disease.

Authors:  Salika M Shakir; Margaret V Powers-Fletcher; E Susan Slechta; Mark A Fisher
Journal:  JMM Case Rep       Date:  2017-11-08

3.  Helicobacter canis bacteraemia in a rheumatoid arthritis patient treated with tofacitinib: case report and literature review.

Authors:  Matic Mihevc; Metka Koren Krajnc; Maja Bombek Ihan; Iztok Holc
Journal:  Ann Clin Microbiol Antimicrob       Date:  2021-04-08       Impact factor: 3.944

Review 4.  Helicobacter canis: A Review of Microbiological and Clinical Features.

Authors:  Benjamin Lardinois; Leïla Belkhir; Alexia Verroken
Journal:  Front Microbiol       Date:  2022-02-23       Impact factor: 5.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.